HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015)-Reference-Cited by-同舟云学术

HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015)

Published:2016-09-08 Issue:11 Volume:26 Page:1257-1272
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Oliveira Eduardo Filipe¹,Santos-Martins Diogo¹,Ribeiro António Meireles¹,Brás Natércia Fernandes¹,Cerqueira Nuno Sousa¹,Sousa Sérgio Filipe¹,Ramos Maria João¹,Fernandes Pedro Alexandrino¹

Affiliation:

1. UCIBIO@REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal

Funder

Fundação para a Ciência e a Tecnologia

NORTE-2020

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2016.1216977

Reference105 articles.

1. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.

2. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

3. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

4. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

5. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesterol Metabolism-Mediated Immune Regulation and Cancer Immunotherapy;2024

2. The Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonist Drugs: A Comprehensive Literature Review;Open Access Macedonian Journal of Medical Sciences;2023-08-04

3. Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review;Journal of Oncology;2022-09-05

4. Detection of 4a,5-dihydropravastatin as Impurity in the Cholesterol Lowering Drug Pravastatin;Molecules;2021-08-03

5. Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab;Current Medicinal Chemistry;2021-04-01